A stimulating new target for cancer immunotherapy.
Schultze
J
J
Department of Adult Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, USA.
Johnson
P
P
D000818:Animals; D019013:CD40 Antigens / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology
D019013:CD40 Antigens